サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541385

エピジェネティクス市場レポート：製品・技術・用途・地域別、2024～2032年

Epigenetics Market Report by Product, Technology, Application, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 149 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
エピジェネティクス市場レポート：製品・技術・用途・地域別、2024～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のエピジェネティクス市場規模は2023年に24億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに72億米ドルに達し、2024～2032年の間に12.6％の成長率（CAGR）を示すと予測しています。

エピジェネティクスは、活性遺伝子と不活性遺伝子の発現における遺伝性の変化を研究する学問です。変化の原因には、環境要因による外的要因と、年齢や病気などの内的要因があります。一般的には、基礎疾患の診断や、次世代への遺伝を防ぐために用いられます。様々な酵素、シーケンサー、スペクトロメーター、ソニケーターなどの機器、試薬、キットを使用します。これらは一般的に、デオキシリボ核酸（DNA）やヒストンのメチル化、非コード化リボ核酸（RNA）、アセチル化、リン酸化に利用されます。その結果、エピジェネティクスは、がん、自己免疫疾患、代謝疾患、心血管疾患、疼痛疾患の診断、モニタリング、治療に広く利用されています。

エピジェネティクス市場傾向

がんと自己免疫不全症候群（AIDS）の世界の有病率の増加は、市場成長を促進する重要な要因の一つです。さらに、非腫瘍性疾患に対するエピジェネティックソリューションの広範な採用が、市場成長の推進力となっています。コロナウイルス病（COVID-19）の突然の流行も、市場関係者に成長機会をもたらしています。例えば、様々な研究機関が、ヒトゲノムに対するウイルスの影響を研究するために高度なエピジェネティック試験を実施しており、早期認識、リスク評価、個別化治療開発のためのツールを開発しています。さらに、アセチラーゼ、メチルトランスフェラーゼ、逆転写酵素、リガーゼなどのDNAとRNA修飾酵素の開発や、高感度で選択性の高い試験や機器の発売も、成長を促す要因として作用しています。これらの技術革新は、ゲノム上の遺伝子座特異的DNAメチル化の評価を容易にします。その他の要因としては、バイオテクノロジーセグメントにおける広範な研究開発（R&D）活動や、特に新興経済諸国における医療インフラの大幅な改善などが挙げられ、市場の成長を後押しすると予想されます。

本レポートで扱う主要質問

  • 世界のエピジェネティクス市場の市場規模は？
  • 2024～2032年にかけての世界のエピジェネティクス市場の予想成長率は？
  • 世界のエピジェネティクス市場を牽引する主要因は何か？
  • 世界のエピジェネティクス市場に対するCOVID-19の影響は？
  • 世界のエピジェネティクス市場の製品別内訳は？
  • 世界のエピジェネティクス市場の技術別内訳は？
  • 世界のエピジェネティクス市場の用途別内訳は？
  • 世界のエピジェネティクス市場における主要地域は？
  • 世界のエピジェネティクス市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のエピジェネティクス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 試薬
  • キット
    • 市場動向
    • 主要セグメント
      • チップシーケンスキット
      • 全ゲノム増幅キット
      • 亜硫酸水素塩変換キット
      • RNAシーケンシングキット
      • その他
    • 市場予測
  • 機器
  • 酵素
  • サービス

第7章 市場内訳：技術別

  • DNAメチル化
  • ヒストンメチル化
  • ヒストンアセチル化
  • 巨大非コードRNA
  • マイクロRNAの修飾
  • クロマチン構造

第8章 市場内訳：用途別

  • 腫瘍学
    • 市場動向
    • 主要セグメント
      • 固形腫瘍
      • 液体腫瘍
    • 市場予測
  • 非腫瘍学
    • 市場動向
    • 主要セグメント
      • 炎症性疾患
      • 代謝性疾患
      • 感染症
      • 心血管疾患
      • その他
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abcam plc
    • Active Motif Inc.
    • Agilent Technologies Inc.
    • Diagenode Diagnostics（Hologic Inc）
    • Illumina Inc.
    • Merck KGaA
    • PerkinElmer Inc.
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
    • Zymo Research Corporation
図表

List of Figures

  • Figure 1: Global: Epigenetics Market: Major Drivers and Challenges
  • Figure 2: Global: Epigenetics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Epigenetics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Epigenetics Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Epigenetics Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Epigenetics Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Epigenetics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Epigenetics (Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Epigenetics (Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Epigenetics (Kits) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Epigenetics (Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Epigenetics (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Epigenetics (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Epigenetics (Enzymes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Epigenetics (Enzymes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Epigenetics (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Epigenetics (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Epigenetics (DNA Methylation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Epigenetics (DNA Methylation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Epigenetics (Histone Methylation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Epigenetics (Histone Methylation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Epigenetics (Histone Acetylation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Epigenetics (Histone Acetylation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Epigenetics (Large Non-Coding RNA) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Epigenetics (Large Non-Coding RNA) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Epigenetics (MicroRNA Modification) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Epigenetics (MicroRNA Modification) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Epigenetics (Chromatin Structures) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Epigenetics (Chromatin Structures) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Epigenetics (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Epigenetics (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Epigenetics (Non-Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Epigenetics (Non-Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: North America: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: North America: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: United States: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: United States: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Canada: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Canada: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Asia-Pacific: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Asia-Pacific: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: China: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: China: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Japan: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Japan: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: India: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: India: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: South Korea: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: South Korea: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Australia: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Australia: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Indonesia: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Indonesia: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Others: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Others: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Europe: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Europe: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Germany: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Germany: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: France: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: France: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: United Kingdom: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: United Kingdom: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Italy: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Italy: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Spain: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Spain: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Russia: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Russia: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Latin America: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Latin America: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Brazil: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Brazil: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Mexico: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Mexico: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Others: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Others: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Middle East and Africa: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Middle East and Africa: Epigenetics Market: Breakup by Country (in %), 2023
  • Figure 82: Middle East and Africa: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Global: Epigenetics Industry: SWOT Analysis
  • Figure 84: Global: Epigenetics Industry: Value Chain Analysis
  • Figure 85: Global: Epigenetics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Epigenetics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Epigenetics Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Epigenetics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Epigenetics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Epigenetics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Epigenetics Market: Competitive Structure
  • Table 7: Global: Epigenetics Market: Key Players
目次
Product Code: SR112024A4096

The global epigenetics market size reached US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.2 Billion by 2032, exhibiting a growth rate (CAGR) of 12.6% during 2024-2032.

Epigenetics refers to the study of heritable changes in the expression of active and inactive genes. The sources of changes can be both external from environmental factors or internal factors, such as age and disease. It is commonly used for the diagnosis of underlying conditions and preventing them from getting transferred to the future generations. It involves the use of various enzymes, instruments, such as sequencers, spectrometers and sonicators, reagents and kits. They are commonly utilized for deoxyribonucleic acid (DNA) and histone methylation, non-coding ribonucleic acid (RNA), acetylation and phosphorylation. As a result, epigenetics is widely used for the diagnosis, monitoring and treatment of oncological, autoimmune, metabolic, cardiovascular and pain disorders.

Epigenetics Market Trends:

The increasing prevalence of cancer and autoimmune deficiency syndrome (AIDS) across the globe is among the key factors driving the market growth. Moreover, the widespread adoption of epigenetic solutions for non-oncological ailments is providing a thrust to the market growth. The sudden outbreak of the coronavirus disease (COVID-19) is also providing growth opportunities to market players. For instance, various research institutes are running advanced epigenetic tests to study the impact of the virus on the human genome and are developing tools for early recognition, risk evaluations and developing personalized treatments. Additionally, the development of DNA and RNA modifying enzymes, such as acetylases, methyltransferases, reverse transcriptase and ligases, and the launch of highly sensitive and selective tests and instruments, are acting as other growth-inducing factors. These innovations facilitate the assessment of locus-specific DNA methylation on a genome. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global epigenetics market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, technology, and application.

Breakup by Product:

Reagents

Kits

Chip Sequencing Kit

Whole Genomic Amplification Kit

Bisulfite Conversion Kit

RNA Sequencing Kit

Others

Instruments

Enzymes

Services

Breakup by Technology:

DNA Methylation

Histone Methylation

Histone Acetylation

Large Non-Coding RNA

MicroRNA Modification

Chromatin Structures

Breakup by Application:

Oncology

Solid Tumors

Liquid Tumors

Non-Oncology

Inflammatory Diseases

Metabolic Diseases

Infectious Diseases

Cardiovascular Diseases

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Active Motif Inc., Agilent Technologies Inc., Diagenode Diagnostics (Hologic Inc), Illumina Inc., Merck KGaA, PerkinElmer Inc., Roche Holding AG, Thermo Fisher Scientific Inc. and Zymo Research Corporation.

Key Questions Answered in This Report

  • 1. How big is the global epigenetics market?
  • 2. What is the expected growth rate of the global epigenetics market during 2024-2032?
  • 3. What are the key factors driving the global epigenetics market?
  • 4. What has been the impact of COVID-19 on the global epigenetics market?
  • 5. What is the breakup of the global epigenetics market based on the product?
  • 6. What is the breakup of the global epigenetics market based on the technology?
  • 7. What is the breakup of the global epigenetics market based on the application?
  • 8. What are the key regions in the global epigenetics market?
  • 9. Who are the key players/companies in the global epigenetics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Epigenetics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Kits
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Chip Sequencing Kit
      • 6.2.2.2 Whole Genomic Amplification Kit
      • 6.2.2.3 Bisulfite Conversion Kit
      • 6.2.2.4 RNA Sequencing Kit
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast
  • 6.3 Instruments
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Enzymes
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Services
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 DNA Methylation
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Histone Methylation
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Histone Acetylation
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Large Non-Coding RNA
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 MicroRNA Modification
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Chromatin Structures
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Key Segments
      • 8.1.2.1 Solid Tumors
      • 8.1.2.2 Liquid Tumors
    • 8.1.3 Market Forecast
  • 8.2 Non-Oncology
    • 8.2.1 Market Trends
    • 8.2.2 Key Segments
      • 8.2.2.1 Inflammatory Diseases
      • 8.2.2.2 Metabolic Diseases
      • 8.2.2.3 Infectious Diseases
      • 8.2.2.4 Cardiovascular Diseases
      • 8.2.2.5 Others
    • 8.2.3 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abcam plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Active Motif Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Agilent Technologies Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Diagenode Diagnostics (Hologic Inc)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Illumina Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Merck KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 PerkinElmer Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Roche Holding AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Thermo Fisher Scientific Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Zymo Research Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio